---
id: buprenorphine
title: Buprenorphine
---
## Indications

* Analgesia

## Adverse effects

* Adverse effects as per other opioids

### Common

* Constipation
* Nausea and vomiting

### Rare

* Anaphylaxis
* Severe itching

## Dose

* Sublingual tablets, 0.2–0.4 mg 6-8 hourly
* Topical preparations (Norspan® patches) multiple sizes, 5-40 mcg/hour changed weekly
* The smallest patch size (5 mcg/hr) is equivalent to about 10 mg oral morphine/day

## Administration advice

* Place the tablets under the tongue until dissolved (takes 2–10 minutes).
* Patches can be placed anywhere on the skin, usually the upper arms or chest.

## Patient advice

* Ensure the patch is adhering completely to the skin (analgesic effect is dependent on this).
* The full analgesic effect will not be felt for 12 hours and will persist for 12 hours post patch removal. It is possible to shower/bathe with the patch in situ.

## Mode of action

* Buprenorphine is a partial opioid receptor agonist (partial agonist effect does not occur at low doses commonly used). 
* Safe in patients with renal impairment
* Usually well tolerated in the elderly.

## Available brands

* Temgesic® 200 mcg sublingual tablets (non PBS)
* Norspan® transdermal patches 5, 10, 15, 20, 30, 40 mcg/hr